Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sharma East India Hospitals & Medical Research (BOM:524548) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Sharma East India Hospitals & Medical Research EBITDA Margin % Related Terms
Sharma East India Hospitals & Medical Research EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sharma East India Hospitals & Medical Research EBITDA Margin % Chart
Sharma East India Hospitals & Medical Research Annual Data
BOM:524548 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Sharma East India Hospitals & Medical Research's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sharma East India Hospitals & Medical Research EBITDA Margin % vs Healthcare Providers & Services Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sharma East India Hospitals & Medical Research (BOM:524548) has a EBITDA Margin % of 13.82% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sharma East India Hospitals & Medical Research and its competitors. This is near median its historical median of 12.85. Over the past decade, Sharma East India Hospitals & Medical Research's EBITDA Margin % has ranged from 10.56 to 26.76. According to the industry distribution chart, Sharma East India Hospitals & Medical Research ranks #325 out of 663 companies in the Healthcare Providers & Services industry, placing it in the top 49%.
Is Sharma East India Hospitals & Medical Research's EBITDA Margin % too high?
Sharma East India Hospitals & Medical Research's current EBITDA Margin % of 13.82% is near median its 10-year median of 12.85. Over the past 10 years, this metric has ranged from a low of 10.56 to a high of 26.76. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Sharma East India Hospitals & Medical Research's value of 13.82% is 35% above this industry median. Based on the distribution chart, Sharma East India Hospitals & Medical Research ranks #325 out of 663 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Sharma East India Hospitals & Medical Research has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sharma East India Hospitals & Medical Research's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Sharma East India Hospitals & Medical Research ranks #325 out of 663 companies for EBITDA Margin %. This puts Sharma East India Hospitals & Medical Research in the upper half of its industry. The industry median EBITDA Margin % is 10.24. Sharma East India Hospitals & Medical Research's value of 13.82% is 35% above this benchmark. Historically, Sharma East India Hospitals & Medical Research's own EBITDA Margin % has ranged from 10.56 to 26.76 over the past decade. While the company's 10-year median is 12.85 vs. the industry median of 10.24, Sharma East India Hospitals & Medical Research has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 663 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sharma East India Hospitals & Medical Research's current EBITDA Margin % of 13.82% is 35% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sharma East India Hospitals & Medical Research and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sharma East India Hospitals & Medical Research's current EBITDA Margin % is 13.82%, which is near median its own 10-year median of 12.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sharma East India Hospitals & Medical Research stock overvalued right now?
Based on GuruFocus' analysis, Sharma East India Hospitals & Medical Research (BOM:524548) is currently considered Fairly Valued. The stock's GF Value™ is ₹102.03, compared to a current price of ₹100.00 — trading 2% below its estimated fair value. The current EBITDA Margin % is 13.82%, which is near median its 10-year median of 12.85 and 35% above the Healthcare Providers & Services industry median of 10.24. Sharma East India Hospitals & Medical Research's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Sharma East India Hospitals & Medical Research (BOM:524548), the current EBITDA Margin % is 13.82% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sharma East India Hospitals & Medical Research (BOM:524548) Overvalued in 2026?
Based on GuruFocus' analysis, Sharma East India Hospitals & Medical Research stock appears to be undervalued.
The current stock price of ₹100.00 is trading 2% below its estimated GF Value™ of ₹102.03.
GuruFocus considers Sharma East India Hospitals & Medical Research to be Fairly Valued.
Key valuation signals for BOM:524548:
EBITDA Margin %: 13.82% (near median its 10-year median of 12.85)
GF Value™: ₹102.03 vs. price of ₹100.00 (2% below fair value)
Industry Position: 35% above the Healthcare Providers & Services median (#325 of 663)
No single metric tells the full story. See the BOM:524548 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sharma East India Hospitals & Medical Research Business Description
Sharma East India Hospitals & Medical Research Ltd is engaged in service activities related to the medical and healthcare services and real estate services. It provides healthcare services through the multi-specialty hospital in the name of Jaipur Hospital in Rajasthan. It provides services like joint replacement surgery, arthroscopy, cardiothoracic and vascular surgery, interventional cardiology, such as angiography and angioplasty, neurosurgery, and others.
77GF Score
Get the complete analysis for BOM:524548
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524548 has been successfully added to your 
